30% (i) 70%(ii) 20% 68.8%50.1%52.1%65.0% 29.9% 36.0% 97.0%26.6%88.8%96.3% 85.0% 85.0%...................... 1 78.4% 441.2 8.4% 15 15 30........................ 1 17.9% 590.9 12.2% 9 17 30................. 1 12.9% 488.0 11.4% 14 15 30.......................... 1 16.8% 361.6 9.2% 10 15 30........................ * 36.0% 87.7 10.6% 20...................... 1 12.2% 196.4 12.0% 1 17 28 * 109
1,000900 49.4%56.6% 30.9%3,000 68.1% 89 24 35 PIC/S 28 29 23.2% 110
926.21,083.9 (i) (ii) 30% (i) 70% (ii) 20% 3,000 68.1% 68.8%50.1%52.1%65.0% 29.9% 36.0% 29 23.2% 9.9%4726.8% 111
PIC/S PIC/S 19.9 27.7 14.2%1,029.31,752.2 11.7% 700 36.1102.0 50.4% 97.0%26.6%88.8%96.3%85.0% 85.0% 2013 2014 2015 2015 112
8.0% 125.3170.8 9.1% 49.4%56.6% 30.9% 1,950 1,000 68.1% 46.6 892435 3669 44 113
Merck (Germany) 5060 36.1 102.0 GMP 1,000 900 114
SAP 30 PIC/S GMP GMP PIC/SPIC/S GMP PIC/SGMP GMP RABS 3,456 2.2 23.5 [ ][] 115
28 GMP 10 PIC/S 700 116
PIC/S 117
44.9 75.3 13.8% 11.2%128.2 10.819.6 37.4 13.8% 30 118
24 89 PIC/SGMP GMP 16 3 49 1,000900 SAP 55.665.8 69.0 17.8%19.6% 19.5% 4.0%5.0% 4.2% 7 18 119
790 39.3%37.0% 35.1% 31.5%29.7% 28.0% 618 108............................................ 11 100%............................... 37 >90%............................. 45 >95%............................. 66 >90%............................... 141 >90%............................................ 597 >95% 1,000 900 1 120 2................ 660.4 738.0 1,081.8 28.8 45.6 28.8 47.0 28.8 51.0 P.E.C. Syrup 120 2............ 431.2 509.5 643.4 38.0 49.0 38.0 50.0 39.0 52.0 20................ 123.8 170.8 168.2 76.4 135.0 75.3 135.0 78.2 135.3 Fendil Syrup 120............. 293.5 319.2 333.7 44.0 45.0 45.0 46.0 46.0 50.0 10100....... 36.6 40.2 43.4 250.0 263.0 263.0 295.0 295.0 329.0 Avastinee Tablets 10 500 3.... 0.4 174.7 204.2 125.0 750.0 69.5 880.0 50.0 880.0 Suphenin Syrup 120 2......... 188.9 222.6 284.4 45.0 46.0 46.0 46.5 46.0 48.0 Glupozide Tablets 80 500 4... 219.6 228.5 164.1 53.6 760.0 81.5 800.0 70.0 880.0 0.3%10.......... 2,160.0 2,204.0 2,419.4 3.9 21.0 4.5 24.0 3.9 26.0 Fendyl Syrup 120............. 178.0 178.0 208.3 44.0 45.0 45.0 46.0 46.0 48.0 1 120
(2) P.E.C. syrup suphenin syrup (3) avastinee tablets 15.3 (4) glupozide tablets.......................... 5,908.3 5,794.8 6,428.3...................... 2,186.2 534.7 2,245.5.................... 79.2 87.8 3,000 700 13................... 1 78.4% 441.2 8.4%..................... 1 17.9% 590.9 12.2%.............. 1 12.9% 488.0 11.4%....................... 1 16.8% 361.6 9.2%..................... * 36.0% 87.7 10.6%................... 1 12.2% 196.4 12.0% * 121
......................................................... 36.0% 122
1,000 900 GMP 66.7%75.0% 83.3% 21 11.9 9.8 123
30 60 90 124............. 12.0 1,580.0 12.4 1,735.0 12.4 1,735.0........... 15.2 294.0 16.0 297.0 16.0 297.0............. 23.2 1,195.0 23.8 1,250.0 23.8 1,250.0 1,000 900 76
100 698.2 79.4%93.0% 90.0% 31.5% 29.7% 28.0% 5.8 104 610.5 412.9 1,000900 1,000 900 125
50,000 GSDP ISO9001 SAP SAP A B A9013 B 40 B A A A B 207.1 306.4 308.4 22.4%32.3% 28.5%18.1 11.0 10.3 126
(i) (ii) 75 4 30 25 1818 18 127
18 10 2% 90 60 (i) (ii) 128
(iii)(iv).................................... 7 7 7......................... (3).................................... 7 7 4 B (i)(ii) (iii) 129
GMPISO 350 7 18 30 90 PIC/SGMP 300 130
................ 150,000 140................ 500.................... 5030........................ 30 80................ 210 131
2,446 2,446 2,292 (1)(3)....... 1,898 1,913 2,166 (%) (2).................. 78 78 95 (4) (1)......... 352,500 307,500 352,500............... 159,162 169,897 162,559 (%) (2).................. 45 55 46 (5) (1)......... 3,311,100 3,311,100 3,538,800............... 2,130,488 2,113,935 2,164,550 (%) (2).................. 64 64 61 (5) (1) 3006 12 (2) (3) 250 (4) 3,456 95% (5) 18 24 132
5 13 6 18 GMP PIC/S GMP GMP 250 150 100 16246 GMP GMP PIC/S GMP 30C GMP 133
138A 27 GMP GMPGMP GMP (i) (ii) (iii) GMP GMP 134
135
GMP 530,000 s.54(1) 4 200,00022 8 14 7 7 8 3 8 2 8 3 22 (i) (ii) 48(iii) (iv) GMP 0.5% 136
......................... (i)(ii) (iii)(iv) 60 90.......................... 0.34 0.95 0.05 1.50 0.04 2.50 137
Facebook Acorn Marketing & Research Consultants (Int l) Ltd 138
7 108 (i) (ii) (iii) (iv) 139
.................................... 7 9 9....................... 2................... (1).................................... 9 9 8 (i)(ii) (iii)(iv) 20% 30% GMP GMPGMP 30 GMP 140
1 3 (1) (3)....................... 222,206 240,365 494,748............................... 143,245 139,155 191,500 (%) (2)................................ 64 58 39 4 (1) 52612 (2) (3) (4) 6070 40 60 GMP 141
HOKLAS 20 r.36(1b) 100,000 2 100,000 2 r.36(1b) 10,000 142
4.33.62.3 13 0.5% 157,000 GMP 143
50,000 ERP (i)(ii) 3.55.75.6 5.5 144
5,000 5 145
89 10 17 21 89 46 59 18 24 146
(1) (2) (3)........................................................ Powder Pharma Coating Inc. (1) (2) (3) 20 [ ][] (i) 147
(ii) 148
(i) (ii) 40 138 PIC/S GMPGMP PIC/SPIC/S GMP PIC/S GMP 149
...... * * GMP......... 138A * *.......... 134 137........ 137 * * * * * * * *........ 134 150
.... 138....... 145........ GMP... 549 * 151
(i)(ii) 6.4 14.2 365 PIC/S GMP PIC/SGMP GMP PIC/S GMP GMPPIC/S GMP GMP PIC (The Convention for the Mutual Recognition of Inspections in Respect of the Manufacture of Pharmaceutical Products) 10 PICPIC PIC(the Pharmaceutical Inspection Co-operation Scheme) PIC PIC/SPIC/S PIC/S 48 PIC PIC/S PIC/S GMP 152
PIC/SPIC/S PIC/S PIC/S47 PIC/SPIC/S PICGMPGMP PIC/SPIC/SGMP PIC/SGMP PIC/S PIC/SPIC/S PIC/SPIC/SGMP PIC/SPIC/S PIC/S PIC/S GMP PIC/S GMP 40 4.5 153
154
1,555 1,400 1551,647................................................ 697 44.8%..................................... 212 13.6%.......................................... 159 10.3%............................................ 126 8.1%................................................ 109 7.0%................................................ 252 16.2%................................................ 1,555 100.0% 207 98 GMP 155
2016 TVB Most Popular TV Commercial Awards Citation for Excellence 2016TVB TVB Online Best Impact Award JPG (BVI) Caring Company Sunday Kiss 2015 Sunday Kiss Top 10 Hong Kong Consumer Product Brands Recommended Brands for Individual Visits Customer s Most Favorable Hong Kong Brands 2014 2013 Jessica Supreme Award JESSICA Mederma for Kids Watson s Health Wellness and Beauty Award Mederma Jessica Baby The Best Seller Jessica Baby Mederma for Kids Jessica Baby Favourite Brands 2013 Hong Kong Top Brand Award Premium Chinese Medicine Enterprise Chinese medicine Promotion award 2015 2014 Jessica Baby 156
Customer s Most Favorable Hong Kong Brands 2013 Superbrands Hong Kong s Choice Roter Customer s Most Favorable Hong Kong Brands 2013 Superbrands Rowachol & Rowatinex & Customer s Most Favorable Hong Kong Brands 2013 157
354C 158
81 2 B. 2. [ ] 159
[ ] (i) (ii) 14* 24,072 * 21,081 GMP 160
31,373 9,435 5836,763 49 141 123 24 14.............................. 161
40(1BA) 24(1) 200,000 20,000 (i) (ii) (a) (b) (c) 10,000 100 153,300 40(6) 162
2424C 24 19 5 19 15 1.8 3.2% 0.3% 0.5 0.2 163
2.3 (i) (ii) [ ] (i) (ii) (i) (ii) 164
(i) (ii) iii (i) (ii) (iii)(iv) v 15,000 98,000 74,000 30,000 165
(i) (ii) (iii)(iv)(v) 184.8 166.2 222.9 13.74.8 28.9 3.083.09 [ ] 166